Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in man.
- 6 July 1993
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 36 (1), 25-30
- https://doi.org/10.1111/j.1365-2125.1993.tb05887.x
Abstract
1. The consequence of the sympatholytic effect of clonidine (alpha 2‐ adrenoceptor agonist) was compared with the effect of a physiological inhibition of sympathetic nervous system activity (change from upright to supine position) on plasma catecholamine and non‐esterified fatty acid (NEFA) concentrations in overnight fasting healthy men. 2. Clonidine (150 micrograms orally) administered in upright position induced a significant reduction of plasma noradrenaline and NEFA concentrations. A change from upright to supine position which provoked a more marked decrease in plasma noradrenaline concentrations induced a weak increase in plasma NEFA concentrations. 3. The modification of plasma NEFA and catecholamine concentrations brought about by standing up was studied after placebo or yohimbine (alpha 2‐adrenoceptor antagonist) administration. With placebo, standing up promotes a 100% increase in plasma noradrenaline concentrations (measured 5 and 15 min after rising) and a weak transient decrease in plasma NEFA concentrations (5 min after rising). In the supine position, yohimbine increased plasma noradrenaline and NEFA concentrations by about 100% and 55% respectively. Standing after yohimbine administration promoted large increases in plasma noradrenaline and NEFA concentrations. 4. These results indicate that a reduction of sympathetic nervous activity is not associated with a decrease of plasma NEFA concentrations and argue for a role of alpha 2‐adrenoceptors in the NEFA mobilization from adipose tissue after sympathetic nervous system activation in man.Keywords
This publication has 26 references indexed in Scilit:
- Yohimbine stimulates colonic motility through a central action in conscious dogsNeurogastroenterology & Motility, 1992
- Contribution of alpha- and beta-receptors to ketogenic and lipolytic effects of norepinephrine in humansDiabetes, 1989
- Heterogeneous distribution of beta and alpha‐2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequencesEuropean Journal of Clinical Investigation, 1987
- Increased α2‐ but similar β‐adrenergic receptor activities in subcutaneous gluteal adipocytes from females compared with malesEuropean Journal of Clinical Investigation, 1986
- Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans.Hypertension, 1983
- Alpha-adrenergic receptors and the regulation of lipolysis in adipose tissueTrends in Pharmacological Sciences, 1981
- Metabolic effects of blood flow restriction in adipose tissueActa Physiologica Scandinavica, 1979
- Vasodilatation and modulation of vasoconstriction in canine subcutaneous adipose tissue caused by activation of β-adrenoceptorsActa Physiologica Scandinavica, 1978
- Human fat cell adenylate cyclase: regional differences in adrenaline responsivenessEuropean Journal of Clinical Investigation, 1977
- Use of plasma norepinephrine for evaluation of sympathetic neuronal function in manLife Sciences, 1976